Browse Category

Financial Analysis News 17 December 2025

Prudential plc (PRU) confirms ICICI Prudential AMC IPO underwriting as capital returns stay in focus — shares touch fresh 52‑week high (17.12.2025)

Prudential plc (PRU) confirms ICICI Prudential AMC IPO underwriting as capital returns stay in focus — shares touch fresh 52‑week high (17.12.2025)

Prudential plc (LSE: PRU) confirmed the underwriting agreement and final prospectus filing for the ICICI Prudential Asset Management IPO, while continuing share repurchases and trading near a new 52‑week high. Prudential plc (LSE: PRU; HKEX: 2378) delivered a busy set of updates on Wednesday, 17 December 2025, putting its India-linked asset management monetisation and shareholder capital returns back in the spotlight. The Asia- and Africa-focused insurer and asset manager confirmed the signing of an underwriting agreement for the ICICI Prudential Asset Management Company (IPAMC) initial public offering and announced the filing of the final prospectus in India. prudentialplc.com At the
Silver Price Today: Silver Breaks $65 to Record High as U.S. Unemployment Rate Hits 4.6%

Silver Price Today: Silver Breaks $65 to Record High as U.S. Unemployment Rate Hits 4.6%

December 17, 2025 — Silver surged to new all-time highs on Wednesday, powering past $65 an ounce for the first time as investors piled into precious metals on a potent mix of tight physical supply, heavy industrial demand, and renewed bets that interest-rate cuts are coming after softer U.S. labor-market data. Gold climbed alongside silver, while platinum and palladium extended a “white metals” rally that has gathered pace into year-end. Reuters Silver’s move is remarkable not just for the headline price, but for what it says about today’s market structure: the demand story is no longer only about safe-haven buying—it’s
Altimmune (ALT) Stock News Today (Dec. 17, 2025): Pemvidutide Catalysts, CEO Transition, and Wall Street Price Targets

Altimmune (ALT) Stock News Today (Dec. 17, 2025): Pemvidutide Catalysts, CEO Transition, and Wall Street Price Targets

Altimmune, Inc. (NASDAQ: ALT) is back in the biotech spotlight on December 17, 2025—less because the company suddenly became “safe,” and more because it’s heading into the kind of binary stretch that turns small-cap biotech charts into roller coasters: a high-stakes clinical update is expected before year-end, leadership is changing hands, and Wall Street price targets remain dramatically spread out. Shares were indicated around $5.03 early Wednesday, after closing at roughly the same level on Tuesday (Dec. 16). MarketBeat Altimmune stock price action: why traders keep circling ALT ALT has been showing the classic behavior of a catalyst-driven biotech: sharp
Unilever (ULVR) Today: Stock Price, Latest News and Key Catalysts After the Magnum Spin‑Off (17 December 2025)

Unilever (ULVR) Today: Stock Price, Latest News and Key Catalysts After the Magnum Spin‑Off (17 December 2025)

Unilever (ULVR) shares closed higher on 17 Dec 2025 as investors track the post‑Magnum strategy, M&A plans, potential UK brand sales, and the Ben & Jerry’s governance dispute. Unilever PLC (LSE: ULVR) ended Wednesday higher in London as the market continues to re-price the consumer-goods giant’s “new look” story: a simplified Unilever following the ice-cream demerger, a sharper focus on Beauty & Wellbeing and Personal Care, and a clearer playbook for bolt‑on acquisitions—while political and governance noise around Ben & Jerry’s shifts to the newly listed Magnum Ice Cream Company. Reuters+3Hargreaves Lansdown+3Reuters+3 Unilever (ULVR) stock price today (17/12/2025): the market
Aditxt (ADTX) Stock Surges After Proxy Filing Sets Up Reverse Split Vote and “bitXbio” Name Change — What to Know on Dec. 17, 2025

Aditxt (ADTX) Stock Surges After Proxy Filing Sets Up Reverse Split Vote and “bitXbio” Name Change — What to Know on Dec. 17, 2025

Aditxt, Inc. (NASDAQ: ADTX) is back in the spotlight on December 17, 2025, after a sharp move tied to a newly filed shareholder proxy—one that tees up high-stakes votes on potential dilution, a possible reverse stock split, and a proposed rebrand to “bitXbio, Inc.” Benzinga+1 This is the kind of micro-cap biotech story that can turn on a single filing: limited liquidity, corporate actions on the table, and a calendar packed with catalysts. Below is what today’s news flow says, what the upcoming votes actually cover, and what market watchers are likely parsing next. Why Aditxt stock is moving today
Comcast (CMCSA) Stock Surges on Activist Investor Buzz as Versant Spinoff Nears: News, Forecasts, and Analyst Targets (Dec. 17, 2025)

Comcast (CMCSA) Stock Surges on Activist Investor Buzz as Versant Spinoff Nears: News, Forecasts, and Analyst Targets (Dec. 17, 2025)

Comcast Corporation (NASDAQ: CMCSA) is having one of those “wait, what just happened?” moments that investors love (or hate) depending on which side of the trade they’re on. As of Dec. 17, 2025, Comcast shares were trading around $29.7, after a sharp ~5% jump that pushed the stock into the day’s most-watched movers list—at a time when the broader market backdrop looked mixed rather than euphoric. Nasdaq+1 So what’s lighting up CMCSA right now? Three overlapping catalysts are dominating today’s Comcast stock narrative: Below is the full breakdown of today’s Comcast stock news, what Wall Street forecasts say CMCSA could
Diageo (DGE.L) Stock News Today: Guinness Maker Strikes $2.3bn Asahi Deal — What It Means for Diageo Shares on 17 December 2025

Diageo (DGE.L) Stock News Today: Guinness Maker Strikes $2.3bn Asahi Deal — What It Means for Diageo Shares on 17 December 2025

Diageo plc stock is firmly in the spotlight on 17 December 2025, after the Johnnie Walker and Guinness owner announced a major East Africa transaction that brings in fresh cash, reduces leverage, and reshapes how the group operates in the region. In a market that has been punishing global spirits makers for slowing demand (especially in the US and parts of Asia), Diageo’s decision to sell its controlling stake in East African Breweries (EABL) to Asahi is being read as more than a simple portfolio tweak. It’s a balance-sheet move, a “simplify the footprint” move, and—depending on your level of
Reckitt Benckiser Group plc (RKT.L) Stock: Buyback Update, Malaysia Distribution Deal and Analyst Forecasts on Dec. 17, 2025

Reckitt Benckiser Group plc (RKT.L) Stock: Buyback Update, Malaysia Distribution Deal and Analyst Forecasts on Dec. 17, 2025

Reckitt Benckiser Group plc shares are heading into the final stretch of 2025 with two storylines that usually play well in consumer staples: steady shareholder returns and incremental, execution-focused growth moves. On Wednesday, December 17, 2025, the FTSE 100 group disclosed another round of share repurchases, while a new Malaysia distribution partnership put fresh emphasis on the company’s consumer health and hygiene portfolio in Southeast Asia. Investegate+1 The bigger backdrop for Reckitt stock remains its multi-year “simplify and focus” strategy: sharpening attention on a smaller set of high-growth “Powerbrands,” leaning harder into emerging markets, and progressing the planned divestment of
SBI Share Price Today: State Bank of India Stock Rises on PSU Bank Rally, Rate Cuts, and Leadership Moves (Dec 17, 2025)

SBI Share Price Today: State Bank of India Stock Rises on PSU Bank Rally, Rate Cuts, and Leadership Moves (Dec 17, 2025)

State Bank of India (NSE: SBIN, BSE: 500112) was among the notable supports for India’s benchmark indices on Wednesday, December 17, 2025, as PSU banking stocks outperformed a choppy broader market. In intraday trade, SBI shares hovered around the ₹975–₹978 zone and were up roughly 1–1.7% versus the previous close, according to live market trackers and exchange-linked market pages. The Economic Times+2Moneycontrol+2 So what’s powering the move? Today’s SBI stock narrative is essentially a three-part mix: sector momentum in PSU banks, fresh leadership/portfolio developments, and the market trying to price the next phase of India’s rate cycle—with SBI already cutting
Sheng Siong Group Ltd Stock (SGX:OV8) Outlook on 17 Dec 2025: STI Reserve List Boost, SG60 Vouchers, and a S$520m Expansion Plan in Focus

Sheng Siong Group Ltd Stock (SGX:OV8) Outlook on 17 Dec 2025: STI Reserve List Boost, SG60 Vouchers, and a S$520m Expansion Plan in Focus

Sheng Siong Group Ltd (SGX:OV8) has become one of Singapore’s most-watched “boring” stocks in 2025 — the kind that sells rice, detergent and fresh seafood, then quietly compounds while the rest of the market debates the future. As of 17 December 2025, the stock traded around S$2.55, down 1.16% on the day, after moving between S$2.51 and S$2.57 with roughly 3.9 million shares traded. Investing.com+1 That price level matters because Sheng Siong is also hovering near its 52-week range of S$1.57 to S$2.73, after a year shaped by three big narratives: Below is a detailed, publication-ready roundup of the latest
Brambles Limited (ASX: BXB) Stock Update: Buy-Back Progress, New Share Quotations, and the Latest Analyst Forecasts (17 December 2025)

Brambles Limited (ASX: BXB) Stock Update: Buy-Back Progress, New Share Quotations, and the Latest Analyst Forecasts (17 December 2025)

SYDNEY — 17 December 2025 — Brambles Limited (ASX: BXB), the global supply-chain logistics group best known for its CHEP pallet pooling network, delivered a cluster of market-facing updates today that matter more for what they signal than for their raw size: steady execution of its FY26 on-market share buy-back, plus two small tranches of ordinary shares slated for quotation under employee incentive arrangements. While none of today’s filings change Brambles’ operating outlook on their own, together they reinforce a familiar 2025–26 narrative for the stock: capital returns via buy-backs, incremental equity issuance from long-running incentive plans, and an investor
Park Medi World IPO Listing 17 December 2025: Shares Debut at Discount on BSE, NSE Despite Strong Subscription — Key Numbers, GMP Signals, and Allotment Check Steps

Park Medi World IPO Listing 17 December 2025: Shares Debut at Discount on BSE, NSE Despite Strong Subscription — Key Numbers, GMP Signals, and Allotment Check Steps

Park Medi World’s much-watched IPO debut delivered a reality check for investors on Wednesday, 17 December 2025, as the hospital-chain operator’s shares listed below the IPO issue price on both major Indian exchanges—despite the offer being subscribed over eight times during the book-building window. On the BSE, Park Medi World opened at ₹155.60, a 3.95% discount to the IPO price of ₹162. On the NSE, the stock listed at ₹158.80, down 1.98% from the issue price. mint+2The Economic Times+2 The listing performance stood out because it came after a “decent-to-strong” subscription response—especially from non-institutional investors (NIIs) and qualified institutional buyers
1 180 181 182 183 184 287

Stock Market Today

Northern Star Resources share price dips into weekend as $50m Central Tanami deal closes

Northern Star Resources share price dips into weekend as $50m Central Tanami deal closes

7 February 2026
Northern Star Resources fell 1.7% to A$26.77 Friday, extending losses as gold miners and the broader market declined. MGX Resources completed its A$50 million purchase of a 50% stake in the Central Tanami Gold Project from Northern Star. The All Ordinaries Gold index dropped 3.24%. CME Group raised COMEX gold futures margin requirements to 9% amid volatility.
PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

7 February 2026
PLS Group shares closed at A$4.12 Friday, down 1.2% after a 3.7% drop Thursday. Morgan Stanley and Mitsubishi UFJ Financial Group disclosed increased voting power in the lithium miner, both citing changes dated Feb. 2. The moves came as lithium prices fell and Australian equities posted their sharpest drop in months. PLS reports interim results Feb. 19.
Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

7 February 2026
Commonwealth Bank of Australia shares closed at A$158.91, down 0.23% Friday, as the S&P/ASX 200 fell 2.03% and nearly A$70 billion was wiped from the market. The bank reports half-year results and an interim dividend on Feb. 11, with shares going ex-dividend Feb. 18. CBA flagged a A$68 million provision linked to ASIC’s Better Banking review. The RBA raised rates to 3.85% on Feb. 3, with CBA passing on the increase from Feb. 13.
Go toTop